CON vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CON

34.9
AI Score
VS
CON Wins

PACS

32.9
AI Score

Investment Advisor Scores

CON

35score
Recommendation
EXTENDED

PACS

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CON PACS Winner
Forward P/E 18.018 15.528 PACS
PEG Ratio 0 1.0347 Tie
Revenue Growth 10.0% 9.1% CON
Earnings Growth 47.0% 51.6% PACS
Tradestie Score 34.9/100 32.9/100 CON
Profit Margin 8.7% 4.9% CON
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY CON

Relative Price Performance (Last 90 Days)

CON 1M: +12.1% · 3M: +24.0% PACS 1M: +12.6% · 3M: +4.3%

Current Technical Phase

CON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.9% over 20 days), RSI 71

RSI (14): 70.9 · Price: $39.09

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.6 · Price: $46.76

Fundamentals Snapshot

Metric CON PACS
Market Cap — —
Forward P/E 21.2 17.1
Trailing P/E 25.0 27.9
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.3% 0.2%
Operating Margin 0.2% 0.1%
EPS 1.55 1.71
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, CON is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.